Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder
NCT00829881
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG:
Betahistine Hydrochloride
DRUG:
Placebo Capsule
Sponsor
P2D, Inc.
Collaborators
[object Object]